Okonogi Siriporn, Naksuriya Ornchuma, Charumanee Suporn, Sirithunyalug Jakkapan
Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Suthep Road, Chiang Mai 50200, Thailand.
Sci Pharm. 2016 Apr 19;84(4):625-633. doi: 10.3390/scipharm84040625.
Curcumin, a poorly water-soluble bioactive compound, was successfully loaded into three different aromatic contents of hydroxypropylmethacrylamide (HPMA)-based polymeric micelles in order to develop water-soluble curcumin nanoformulations (Cur-Nano). The stability study of Cur-Nano was done by keeping the formulations at 4, 30, and 40 °C for 90 days. The physical appearance, curcumin remaining, and particle size of Cur-Nano were examined by visual inspection, high-performance liquid chromatography, and dynamic light scattering, respectively. After the storage period, the Cur-Nano composed of 100% aromatic-substituted polymer exhibited the highest stability of curcumin (80% of curcumin remaining) with a similar particle size as measured on the first day (50-60 nm) in all storage conditions. Curcumin in Cur-Nano composed of 25% and 0% aromatic-substituted polymer was significantly less stable accordingly. The results suggested that aromatic substitution to HPMA-based polymeric micelles can significantly enhance the stability of the loaded curcumin, considerably due to the π-π stacking interactions between the aromatic groups of curcumin and the polymer. It is concluded that curcumin-loaded polymeric micelles with high substituted aromatic content can be promising candidates with good storage stability for further clinical evaluations.
姜黄素是一种水溶性较差的生物活性化合物,为了开发水溶性姜黄素纳米制剂(Cur-Nano),它被成功载入三种不同芳香含量的基于羟丙基甲基丙烯酰胺(HPMA)的聚合物胶束中。通过将制剂分别在4℃、30℃和40℃下保存90天来进行Cur-Nano的稳定性研究。分别通过目视检查、高效液相色谱法和动态光散射法检测Cur-Nano的物理外观、剩余姜黄素和粒径。储存期过后,由100%芳香取代聚合物组成的Cur-Nano在所有储存条件下均表现出最高的姜黄素稳定性(剩余80%的姜黄素),且粒径与第一天测量的相似(50 - 60纳米)。相应地,由25%和0%芳香取代聚合物组成的Cur-Nano中的姜黄素稳定性明显较低。结果表明,对基于HPMA的聚合物胶束进行芳香取代可显著提高所载姜黄素的稳定性,这主要归因于姜黄素的芳香基团与聚合物之间的π-π堆积相互作用。得出的结论是,具有高取代芳香含量的载姜黄素聚合物胶束有望成为具有良好储存稳定性的候选物,以供进一步的临床评估。